MedPath

Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders

Not Applicable
Completed
Conditions
Menopause
Bipolar Disorder
Major Depressive Disorder
Registration Number
NCT02860910
Lead Sponsor
Danette Conklin, PhD
Brief Summary

The general objective of this study is to advance insight into non-pharmacological treatments for maturing women that impact psychological health and wellbeing of women adapting to menopause, a natural but often challenging developmental milestone.

Detailed Description

This exploratory study proposes to expand the knowledge in the menopausal literature and evaluate the effectiveness of cognitive-behavioral group therapy (CBGT) in reducing problematic vasomotor symptoms, reducing daily interference and improving quality of life. The study will include two homogenous peri- or post-menopausal cohorts (African-American and Caucasian) with major depressive disorder or bipolar disorder. The intervention will be delivered in groups of 6 to 10 participants per group of both race/ethnicities in an outpatient setting during a 6-week time period. The participants will be assessed on the degree of hot flash problem rating, hot flash related daily interference, and menopause quality of life at screening, baseline, and post-treatment. Participants will also be assessed using the following predictor variables at the same time points: body mass index (BMI), level of perceived stress, severity of depression, severity of anxiety level of pleasure, severity of mania, hot flash beliefs and severity of couple's conflict.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
59
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of participants who begin cognitive group behavioral therapy2 years
Change in Hot Flush Rating Scale: Frequency and Problem Rating (HFRS) total scoreBaseline and Week 6
Secondary Outcome Measures
NameTimeMethod
Change in Menopause Representation Questionnaire (MRQ) total scoreBaseline and Week 6
Change in Hot Flash Daily Interference Scale (HFRDIS) total scoreBaseline and Week 6

Trial Locations

Locations (1)

University Hospitals Cleveland Medical Center - Mood Disorders Program

🇺🇸

Cleveland, Ohio, United States

University Hospitals Cleveland Medical Center - Mood Disorders Program
🇺🇸Cleveland, Ohio, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.